• SKIP TO CONTENT
  • SKIP NAVIGATION
  • Patient Resources
    • COVID-19 Patient Resource Center
    • Clinical Trials
    • Search Clinical Trials
    • Patient Notification System
    • What is Clinical Research?
    • Volunteering for a Clinical Trial
    • Understanding Informed Consent
    • Useful Resources
    • FDA Approved Drugs
  • Professional Resources
    • Research Center Profiles
    • Clinical Trial Listings
    • Market Research
    • FDA Approved Drugs
    • Training Guides
    • Books
    • eLearning
    • Events
    • Newsletters
    • White Papers
    • SOPs
    • eCFR and Guidances
  • White Papers
  • Trial Listings
  • Advertise
  • COVID-19
  • iConnect
  • Sign In
  • Create Account
  • Sign Out
  • My Account
Home » Baxter, MATTER partner on patient-driven innovation

Baxter, MATTER partner on patient-driven innovation

September 1, 2017
CenterWatch Staff

Baxter International, a global medical products company, and MATTER, a Chicago-based healthcare incubator and innovation community, announced a new collaboration to drive forward innovation focused on improving the value and quality of healthcare.

The collaboration will bring together Baxter’s strategy and product development teams and MATTER’s network of entrepreneurs and innovators to help advance new ideas, products and technology that can make a meaningful difference in healthcare.

“Baxter is one of the world’s great healthcare companies, with products in hospitals around the globe,” said Steven Collens, MATTER CEO. “MATTER is thrilled to partner with Baxter to create collaborations with entrepreneurs that will help develop next-generation products and solutions to improve health and lives."

As part of the agreement, Baxter will provide resources and expertise to help entrepreneurs accelerate the progress of their innovations, and collaborate on the development of new technologies to help address pressing unmet clinical needs. In addition, Baxter will gain access to MATTER’s extensive program suite, including introductions to member companies, proprietary access to relevant technologies under development through MATTER partners, and the opportunity to explore MATTER’s entrepreneurial network to pursue key business objectives.

“Our work with MATTER will help Baxter provide meaningful support for healthcare innovation in Chicago,” said David Roman, vice president of strategy for Baxter’s global businesses. “Our partnership with MATTER extends Baxter’s efforts to access new sources of innovation. Importantly, we can help advance new ideas that have the potential to greatly improve healthcare here and around the world.”

This new partnership builds on Baxter’s recently announced research collaborations with Mayo Clinic, Tel Aviv University and Tel Aviv Sourasky Medical Center.

Upcoming Events

  • 16Feb

    Fundamentals of FDA Inspection Management: Reduce Anxiety, Increase Inspection Success

  • 21May

    WCG MAGI Clinical Research Conference – 2023 East

Featured Products

  • Spreadsheet Validation: Tools and Techniques to Make Data in Excel Compliant

    Spreadsheet Validation: Tools and Techniques to Make Data in Excel Compliant

  • Surviving an FDA GCP Inspection

    Surviving an FDA GCP Inspection: Resources for Investigators, Sponsors, CROs and IRBs

Featured Stories

  • SurveywBlueBackground-360x240.png

    Sites Name Tech Acceptance as Essential Factor in Selection of Sponsors, Survey Finds

  • TrendsInsights2023-360x240.png

    WCG Clinical Research Trends and Insights for 2023, Part Two

  • TimeMoneyEffort-360x240.png

    Time is Money and So Is Effort, Budgeting Experts Say

  • TrendsInsights2023A-360x240.png

    WCG Clinical Research Trends and Insights for 2023, Part Three

Standard Operating Procedures for Risk-Based Monitoring of Clinical Trials

The information you need to adapt your monitoring plan to changing times.

Learn More Here
  • About Us
  • Contact Us
  • Privacy Policy
  • Do Not Sell or Share My Data

Footer Logo

300 N. Washington St., Suite 200, Falls Church, VA 22046, USA

Phone 617.948.5100 – Toll free 866.219.3440

Copyright © 2023. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing